Aberrant Protein S-Nitrosylation Mimics the Effect of Rare Genetic Mutations in Neurodegenerative Diseases.

Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Lewy body dementia and amyotrophic lateral sclerosis (ALS), represent some of the most complex challenges in modern medicine. These diseases gradually damage brain cells, leading to memory loss, movement problems, and changes in behavior and thinking. These conditions are driven by a shifting balance between our genetic blueprints and the environments we live in. While large-scale genetic studies have identified several "risk genes", such as APOE or SNCA (the gene encoding the alpha-synuclein protein), that increase a person's vulnerability, these genetic factors alone cannot fully explain why the disease begins or how quickly it progresses. Many patients develop these devastating conditions without any clear family history, suggesting that environmental triggers play a far more significant role than previously understood. Our research bridges this gap by identifying a critical molecular link called S-nitrosylation, which decorated proteins chemically with SNO. In a healthy brain, SNO acts as a subtle chemical "switch" that helps regulate normal cellular functions, akin to phosphorylation. However, when the brain is exposed to environmental stress, such as toxins/inflammation/aging, this switch malfunctions. We have pioneered the concept of "Mutational Mimicry" to describe this phenomenon. We discovered that when this chemical process goes wrong, it attaches to key proteins in the brain and disrupts their function in the exact same way a rare, harmful genetic mutation would. Essentially, environmental stress can chemically "reprogramm" healthy proteins to behave in a defective manner. Our analysis of diseased human brain tissue provides striking evidence for this theory: The specific proteins damaged by abnormal SNO chemical switches overlap significantly with known gene risk factors for Alzheimer’s and Parkinson’s diseases, i.e., the genes that encode these proteins that can be decorated with SNO are often found to be risk genes for the neurological disorder if mutate. This convergence shows that environmental factors leading to aberrant SNO can essentially "copy" or amplify the destructive effects of high-risk genes. This process leads to a catastrophic failure of the brain’s "energy factories" (mitochondria), a breakdown in cellular waste management (proteostasis), and a rise in harmful neuroinflammation, all of which eventually destroy the connections between nerve cells. By uncovering how these environmental and genetic pathways collide, our work moves beyond just describing the damage. It points toward a transformative therapeutic strategy: if we can develop new drugs to prevent or correct these faulty chemical switches, we may be able to protect the brain's proteins before they are permanently compromised. This approach offers hope for a new generation of treatments designed not just to manage symptoms, but to halt the progression of neurodegenerative diseases by intervening at the very point where environmental and biology meet.